197 related articles for article (PubMed ID: 34845942)
1. Novel Adenosine Deaminase 2 (ADA2) Mutations Associated With Hematological Manifestations.
Albalawi R; Hanafy E; Alnafea H; Altowijiry M; Riyad S; Abufara F; Albolowi N
J Investig Med High Impact Case Rep; 2021; 9():23247096211056770. PubMed ID: 34845942
[TBL] [Abstract][Full Text] [Related]
2. A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2.
Özen S; Batu ED; Taşkıran EZ; Özkara HA; Ünal Ş; Güleray N; Erden A; Karadağ Ö; Gümrük F; Çetin M; Sönmez HE; Bilginer Y; Ayvaz DÇ; Tezcan I
J Rheumatol; 2020 Jan; 47(1):117-125. PubMed ID: 31043544
[TBL] [Abstract][Full Text] [Related]
3. Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment.
Meyts I; Aksentijevich I
J Clin Immunol; 2018 Jul; 38(5):569-578. PubMed ID: 29951947
[TBL] [Abstract][Full Text] [Related]
4. Deficiency of Adenosine Deaminase 2 (DADA2), an Inherited Cause of Polyarteritis Nodosa and a Mimic of Other Systemic Rheumatologic Disorders.
Hashem H; Kelly SJ; Ganson NJ; Hershfield MS
Curr Rheumatol Rep; 2017 Oct; 19(11):70. PubMed ID: 28983775
[TBL] [Abstract][Full Text] [Related]
5. Deficiency of Adenosine Deaminase 2 (DADA2): Hidden Variants, Reduced Penetrance, and Unusual Inheritance.
Schnappauf O; Zhou Q; Moura NS; Ombrello AK; Michael DG; Deuitch N; Barron K; Stone DL; Hoffmann P; Hershfield M; Applegate C; Bjornsson HT; Beck DB; Witmer PD; Sobreira N; Wohler E; Chiorini JA; Center TAG; Dalgard CL; Center NIS; Kastner DL; Aksentijevich I
J Clin Immunol; 2020 Aug; 40(6):917-926. PubMed ID: 32638197
[TBL] [Abstract][Full Text] [Related]
6. Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2).
Lee PY; Kellner ES; Huang Y; Furutani E; Huang Z; Bainter W; Alosaimi MF; Stafstrom K; Platt CD; Stauber T; Raz S; Tirosh I; Weiss A; Jordan MB; Krupski C; Eleftheriou D; Brogan P; Sobh A; Baz Z; Lefranc G; Irani C; Kilic SS; El-Owaidy R; Lokeshwar MR; Pimpale P; Khubchandani R; Chambers EP; Chou J; Geha RS; Nigrovic PA; Zhou Q
J Allergy Clin Immunol; 2020 Jun; 145(6):1664-1672.e10. PubMed ID: 31945408
[TBL] [Abstract][Full Text] [Related]
7. Refractory Pure Red Cell Aplasia Manifesting as Deficiency of Adenosine Deaminase 2.
Hashem H; Egler R; Dalal J
J Pediatr Hematol Oncol; 2017 Jul; 39(5):e293-e296. PubMed ID: 28230570
[TBL] [Abstract][Full Text] [Related]
8. A new CECR1 mutation associated with severe hematological involvement in ADA2 deficiency.
Nicoară D; Niță C; Stanilă A; Martiniuc A; Popa L; Petrescu E; Bătăneant M; Ciofu R; Guriță A; Tabăcaru R; Ionescu R; Groșeanu L
Immun Inflamm Dis; 2023 Aug; 11(8):e930. PubMed ID: 37647436
[TBL] [Abstract][Full Text] [Related]
9. A case report on deficiency of adenosine deaminase 2 with relapse-remission course and analysis of genotype-phenotype correlation.
Cai Q; Feng F; Tian Y; Luo R; Mu D; Yang F; Yang Z; Zhou Z
Am J Med Genet A; 2024 Jun; 194(6):e63568. PubMed ID: 38353426
[TBL] [Abstract][Full Text] [Related]
10. Adenosine Deaminase Two and Immunoglobulin M Accurately Differentiate Adult Sneddon's Syndrome of Unknown Cause.
Santo GC; Baldeiras I; Guerreiro R; Ribeiro JA; Cunha R; Youngstein T; Nanthapisal S; Leitão J; Fernandes C; Caramelo F; Almeida MDR; Brás J; Santana I;
Cerebrovasc Dis; 2018; 46(5-6):257-264. PubMed ID: 30645994
[TBL] [Abstract][Full Text] [Related]
11. Novel Mutation in CECR1 Leads to Deficiency of ADA2 with Associated Neutropenia.
Cipe FE; Aydogmus C; Serwas NK; Keskindemirci G; Boztuğ K
J Clin Immunol; 2018 Apr; 38(3):273-277. PubMed ID: 29564582
[TBL] [Abstract][Full Text] [Related]
12. A Novel Germline Mutation of
Vai S; Marin E; Cosso R; Saettini F; Bonanomi S; Cattoni A; Chiodini I; Persani L; Falchetti A
Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361096
[TBL] [Abstract][Full Text] [Related]
13. Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency.
Barzaghi F; Cicalese MP; Zoccolillo M; Brigida I; Barcella M; Merelli I; Sartirana C; Zanussi M; Calbi V; Bernardo ME; Tucci F; Migliavacca M; Giglio F; Doglio M; Canarutto D; Ferrua F; Consiglieri G; Prunotto G; Saettini F; Bonanomi S; Rovere-Querini P; Di Colo G; Jofra T; Fousteri G; Penco F; Gattorno M; Hershfield MS; Bongiovanni L; Ponzoni M; Marktel S; Milani R; Peccatori J; Ciceri F; Mortellaro A; Aiuti A
Front Immunol; 2022; 13():910021. PubMed ID: 36248833
[TBL] [Abstract][Full Text] [Related]
14. A case series of ten plus one deficiency of adenosine deaminase 2 (DADA2) patients in Iran.
Asna Ashari K; Aslani N; Parvaneh N; Assari R; Heidari M; Fathi M; Tahghighi Sharabian F; Ronagh A; Shahrooei M; Moafi A; Rezaei N; Ziaee V
Pediatr Rheumatol Online J; 2023 Jun; 21(1):55. PubMed ID: 37312195
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of Adenosine Deaminase Type 2: A Description of Phenotype and Genotype in Fifteen Cases.
Nanthapisal S; Murphy C; Omoyinmi E; Hong Y; Standing A; Berg S; Ekelund M; Jolles S; Harper L; Youngstein T; Gilmour K; Klein NJ; Eleftheriou D; Brogan PA
Arthritis Rheumatol; 2016 Sep; 68(9):2314-22. PubMed ID: 27059682
[TBL] [Abstract][Full Text] [Related]
16. Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment.
Pinto B; Deo P; Sharma S; Syal A; Sharma A
Clin Rheumatol; 2021 Oct; 40(10):3883-3896. PubMed ID: 33791889
[TBL] [Abstract][Full Text] [Related]
17. Case Report: Interindividual variability and possible role of heterozygous variants in a family with deficiency of adenosine deaminase 2: are all heterozygous born equals?
Pulvirenti F; Cinicola BL; Ferrari S; Guadagnolo D; Sculco E; Capponi M; Loffredo L; Sciannamea M; Insalaco A; Quinti I; De Benedetti F; Zicari AM
Front Immunol; 2023; 14():1156689. PubMed ID: 37207212
[TBL] [Abstract][Full Text] [Related]
18. Novel adenosine deaminase 2 mutations in a child with a fatal vasculopathy.
Garg N; Kasapcopur O; Foster J; Barut K; Tekin A; Kızılkılıç O; Tekin M
Eur J Pediatr; 2014 Jun; 173(6):827-30. PubMed ID: 24737293
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune phenotype with type I interferon signature in two brothers with ADA2 deficiency carrying a novel CECR1 mutation.
Skrabl-Baumgartner A; Plecko B; Schmidt WM; König N; Hershfield M; Gruber-Sedlmayr U; Lee-Kirsch MA
Pediatr Rheumatol Online J; 2017 Aug; 15(1):67. PubMed ID: 28830446
[TBL] [Abstract][Full Text] [Related]
20. Adult-onset deficiency of adenosine deaminase 2-a case report and literature review.
Zhang B; Sun Y; Xu N; Wang W; Huang X; Chen J; Shen M; Wang R; Zeng X; Zhang X
Clin Rheumatol; 2021 Oct; 40(10):4325-4339. PubMed ID: 33638065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
